减轻中老年人头晕负担:多因素定制化单盲随机对照试验
该6个月单盲平行组随机对照试验纳入305名50岁及以上社区居住头晕者,干预组接受多学科评估后的定制化多模式干预,对照组接受常规护理。结果显示干预组DHI评分较对照组显著降低,但头晕发作频率、CSRT和步态变异性无显著组间差异。结论支持个体化多模式循证治疗可减轻中老年人头晕相关自我感知残疾。
要点
- 多学科定制化干预可显著降低中老年人DHI评分。
- 头晕发作频率、CSRT和步态变异性未见显著改善。
- 干预未发生严重不良事件,但CBT和跌倒门诊 uptake 一般。
核心结论
- 多因素定制化干预可有效降低50岁及以上社区居住头晕者的头晕残疾程度。
- 其他主要结局指标未见显著组间差异,研究支持实施个体化多模式循证治疗。
研究设计与样本
- 6个月单盲平行组随机对照试验,纳入305名50至92岁社区居住且过去一年有头晕症状者。
- 随机分为常规护理对照组(n=151)和定制化多模式干预组(n=154)。
- 干预组接受物理治疗师主导的前庭康复(35%)、8周网络认知行为治疗(19%)、6个月Otago家庭锻炼(24%)和/或医疗管理(40%)。
- 由老年科医生、前庭神经科学家、心理学家、运动生理学家等组成团队每两周开病例会议制定干预。
- 意向性治疗分析纳入274名参与者(90%;每组137名)。
主要发现
- 干预组DHI评分前后均值(SD)分别为25.9(19.2)和20.4(17.7),对照组分别为23.0(15.8)和21.8(16.4)。
- 控制基线评分后,DHI评分组间差异(基线调整)为-3.7(95%CI -6.2至-1.2;p=0.003)。
- 头晕发作频率组间相对风险(RR)为0.87(95%CI 0.65至1.17;p=0.360)。
- CSRT表现组间差异(基线调整)为-15(95%CI -40至10;p=0.246)。
- 步态步时变异性组间差异(基线调整)为-0.001(95%CI -0.002至0.001;p=0.497)。
关键数值与推荐
- DHI评分组间基线调整差异为-3.7(95%CI -6.2至-1.2;p=0.003),干预组优于对照组。
- 头晕发作频率RR为0.87(95%CI 0.65至1.17;p=0.360),无显著差异。
- CSRT表现组间差异为-15(95%CI -40至10;p=0.246),无显著差异。
- 步态步时变异性组间差异为-0.001(95%CI -0.002至0.001;p=0.497),无显著差异。
- 未发生严重干预相关不良事件。
临床怎么用
- 对50岁及以上社区居住头晕者,可考虑多学科评估后实施定制化多模式干预以减轻头晕残疾。
- 干预可包括前庭康复、认知行为治疗、家庭锻炼和/或医疗管理,根据个体评估选择。
- 需注意该干预对头晕发作频率、反应时间和步态变异性未见显著改善。
局限性
- 参与者初始头晕严重程度较低。
- 跌倒门诊(医疗管理)和CBT干预的接受度仅一般。
- 71名参与者(占总样本23%)未能确定头晕病因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dizziness is common among older people and is associated with a cascade of debilitating symptoms, such as reduced quality of life, depression, and falls. The multifactorial aetiology of dizziness is a major barrier to establishing a clear diagnosis and offering effective therapeutic interventions. Only a few multidisciplinary interventions of dizziness have been conducted to date, all of a pilot nature and none tailoring the intervention to the specific causes of dizziness. Here, we aimed to test the hypothesis that a multidisciplinary dizziness assessment followed by a tailored multifaceted intervention would reduce dizziness handicap and self-reported dizziness as well as enhance balance and gait in people aged 50 years and over with dizziness symptoms. METHODS AND FINDINGS: We conducted a 6-month, single-blind, parallel-group randomized controlled trial in community-living people aged 50 years and over who reported dizziness in the past year. We excluded individuals currently receiving treatment for their dizziness, those with degenerative neurological conditions including cognitive impairment, those unable to walk 20 meters, and those identified at baseline assessment with conditions that required urgent treatment. Our team of geriatrician, vestibular neuroscientist, psychologist, exercise physiologist, study coordinator, and baseline assessor held case conferences fortnightly to discuss and recommend appropriate therapy (or therapies) for each participant, based on their multidisciplinary baseline assessments. A total of 305 men and women aged 50 to 92 years (mean [SD] age: 67.8 [8.3] years; 62% women) were randomly assigned to either usual care (control; n = 151) or to a tailored, multifaceted intervention (n = 154) comprising one or more of the following: a physiotherapist-led vestibular rehabilitation programme (35% [n = 54]), an 8-week internet-based cognitive-behavioural therapy (CBT) (19% [n = 29]), a 6-month Otago home-based exercise programme (24% [n = 37]), and/or medical management (40% [n = 62]). We were unable to identify a cause of dizziness in 71 participants (23% of total sample). Primary outcome measures comprised dizziness burden measured with the Dizziness Handicap Inventory (DHI) score, frequency of dizziness episodes recorded with monthly calendars over the 6-month follow-up, choice-stepping reaction time (CSRT), and gait variability. Data from 274 participants (90%; 137 per group) were included in the intention-to-treat analysis. At trial completion, the DHI scores in the intervention group (pre and post mean [SD]: 25.9 [19.2] and 20.4 [17.7], respectively) were significantly reduced compared with the control group (pre and post mean [SD]: 23.0 [15.8] and 21.8 [16.4]), when controlling for baseline scores (mean [95% CI] difference between groups [baseline adjusted]: -3.7 [-6.2 to -1.2]; p = 0.003). There were no significant between-group differences in dizziness episodes (relative risk [RR] [95% CI]: 0.87 [0.65 to 1.17]; p = 0.360), CSRT performance (mean [95% CI] difference between groups [baseline adjusted]: -15 [-40 to 10]; p = 0.246), and step-time variability during gait (mean [95% CI] difference between groups [baseline adjusted]: -0.001 [-0.002 to 0.001]; p = 0.497). No serious intervention-related adverse events occurred. Study limitations included the low initial dizziness severity of the participants and the only fair uptake of the falls clinic (medical management) and the CBT interventions. CONCLUSIONS: A multifactorial tailored approach for treating dizziness was effective in reducing dizziness handicap in community-living people aged 50 years and older. No difference was seen on the other primary outcomes. Our findings therefore support the implementation of individualized, multifaceted evidence-based therapies to reduce self-perceived disability associated with dizziness in middle-aged and older people. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry ACTRN12612000379819.
引用
- Menant JC, Migliaccio AA, Sturnieks DL, et al. Reducing the burden of dizziness in middle-aged and older people: A multifactorial, tailored, single-blind randomized controlled trial. PLoS Med. 2018. PMID: 30040818. doi:10.1371/journal.pmed.1002620
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。